Total Funding: 63200000
Headquarters: Los Angeles, California, United States
Funding Status: Early Stage Venture
Last Funding Type: Series B
Technology: Rare Genetic Disorders
Last Funding Date: 2022-11-28
Investors Number: 18
Founded Date: 2016-01-01
Industry: Early Drug Development